Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women

OBJECTIVE: To review the pharmacological properties and the available clinical data of full length parathyroid hormone (PTH) in post-menopausal osteoporosis. SOURCES: A MEDLINE search was completed, together with a review of information obtained from the manufacturer and from the medicine regulatory...

Descripción completa

Detalles Bibliográficos
Autor principal: Jódar-Gimeno, Esteban
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684083/
https://www.ncbi.nlm.nih.gov/pubmed/18044089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684083/
https://www.ncbi.nlm.nih.gov/pubmed/18044089

Ejemplares similares